HeartStitch taps ex-BSX’s Dunn as new Reg, QA director
HeartStitch said Wednesday it appointed Faye Dunn as its new director of regulatory affairs and quality assurance.
Prior to her time at HeartStitch, Dunn held positions at both Boston Scientific (NYSE:BSX) and Fujifilm Holdings (TSE:4901), the company said.
“Faye positively impressed us over the course of multiple interviews, and her presence within the company has brought a positive and immediate impact to all of our processes. We were looking for a unique combination of previous experience — including quality management, risk assessment, design controls, and international product registrations. Ours is a very fast-paced environment where creativity and skills in interpersonal dynamics are essential. We are confident after her first few weeks on the job that she will prove a great asset to the company, our physicians, and our shareholders,” CEO Anthony Nobles said in a press release.
